Enanta Pharmaceuticals, Inc.ENTANASDAQ
Loading
Selling, general, and administrative expenses
3Y CAGR
-8.8%/yr
vs +19.1%/yr prior
5Y CAGR
+4.3%/yr
Recent deceleration
Acceleration
-28.0pp
Decelerating
Percentile
P73
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $40.10M | -8.7% |
| 2025 | $43.93M | -24.1% |
| 2024 | $57.85M | +9.4% |
| 2023 | $52.89M | +16.3% |
| 2022 | $45.48M | +39.8% |
| 2021 | $32.54M | +18.9% |
| 2020 | $27.36M | +4.2% |
| 2019 | $26.25M | +12.0% |
| 2018 | $23.44M | +13.0% |
| 2017 | $20.75M | - |